16.39
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cogent Biosciences Inc Borsa (COGT) Ultime notizie
Relative strength of Cogent Biosciences Inc. in sector analysisEarnings Overview Report & Weekly High Potential Stock Alerts - newser.com
How strong is Cogent Biosciences Inc. stock revenue growthJuly 2025 Trends & Risk Controlled Daily Trade Plans - newser.com
Momentum divergence signals in Cogent Biosciences Inc. chartMarket Growth Review & Verified Technical Trade Signals - newser.com
Cushman & Wakefield arranges 31,518 s/f for Cogent Biosciences, Inc. at 180 CityPoint - NEREJ
Stifel Initiates Coverage of Cogent Biosciences (COGT) with Hold Recommendation - Nasdaq
Is Cogent Biosciences Inc. stock a buy before product launchesGold Moves & Real-Time Price Movement Reports - newser.com
Visualizing Cogent Biosciences Inc. stock with heatmapsMarket Volume Summary & Expert Curated Trade Setups - newser.com
Stifel Initiates Coverage on Cogent Biosciences (COGT) with Hold Rating | COGT Stock News - GuruFocus
Cogent Biosciences Inc Stock Analysis and ForecastSector Leadership Analysis & Superior Wealth Building - earlytimes.in
Is Cogent Biosciences Inc a good long term investmentQuarterly Earnings Review & Swing Trade Smarter With Data Insights - earlytimes.in
Volume spikes in Cogent Biosciences Inc. stock – what they meanTrade Analysis Report & Low Drawdown Investment Strategies - newser.com
Cogent Biosciences (NASDAQ:COGT) Stock Price Passes Below Fifty Day Moving Average of $12.64 - 富途牛牛
13 Biotech Stocks Charging Ahead With New 52-week HighsWill Near-term Catalysts Drive More Gains? - RTTNews
Cogent Biosciences Soars to 52-Week High on "Breakthrough" Systemic Mastocytosis Trial Results - FinancialContent
Cogent Biosciences (NASDAQ:COGT) Reaches New 1-Year HighWhat's Next? - MarketBeat
Cogent Biosciences stock hits 52-week high at 16.49 USD - Investing.com
Will Cogent Biosciences Inc. stock outperform tech sector in 2025Weekly Earnings Recap & Verified Momentum Stock Alerts - newser.com
Will Cogent Biosciences Inc. stock split attract more investorsJuly 2025 Outlook & Intraday High Probability Setup Alerts - newser.com
Sentiment analysis tools applied to Cogent Biosciences Inc.Trade Volume Report & Real-Time Buy Zone Alerts - newser.com
Cogent Biosciences, Inc. (COGT): Analyst Ratings Point To A Promising 30% Upside - DirectorsTalk Interviews
Will earnings trigger a reversal in Cogent Biosciences Inc.Dividend Hike & Stepwise Swing Trade Plans - newser.com
Visual trend scoring systems applied to Cogent Biosciences Inc.July 2025 Patterns & Fast Moving Trade Plans - newser.com
Cogent Biosciences (NASDAQ:COGT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat
Cogent Biosciences Inc. stock outlook for YEARJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Cogent Biosciences (NASDAQ:COGT) Hits New 52-Week HighHere's Why - MarketBeat
Historical volatility pattern of Cogent Biosciences Inc. visualizedEarnings Risk Report & High Yield Stock Recommendations - newser.com
Published on: 2025-10-05 05:47:04 - newser.com
When is the best time to exit Cogent Biosciences Inc.CEO Change & Daily Entry Point Alerts - newser.com
Cogent Biosciences Relocates Headquarters to BXP’s 180 CityPoint - Connect CRE
Cogent Biosciences patents new GTPase KRAS inhibitors - BioWorld MedTech
Published on: 2025-10-03 00:35:36 - newser.com
Is Cogent Biosciences Inc. building a consolidation basePortfolio Return Report & Precise Trade Entry Recommendations - newser.com
Cogent Biosciences Inc. (COGT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cogent Biosciences stock hits 52-week high at 14.55 USD By Investing.com - Investing.com Nigeria
Cogent Biosciences stock hits 52-week high at 14.55 USD - Investing.com
Platinum Investment Management Ltd. Boosts Stock Position in Cogent Biosciences, Inc. $COGT - MarketBeat
Biotech planning to seek first-ever FDA approval signs new Waltham lease - The Business Journals
Cushman & Wakefield Arranges 31,500-Square-Foot Lease for Cogent Biosciences in Greater Boston - Cushman & Wakefield
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):